Roncadelle Operations
Private Company
Funding information not available
Overview
Roncadelle Operations is a private, revenue-generating MedTech company and CDMO with over four decades of experience, headquartered in Castel Mella, Italy. The company operates through two synergistic pillars: the proprietary SafeR® platform of passive safety syringe systems designed to prevent needlestick injuries, and a comprehensive CDMO service offering for the development and manufacturing of complex drug delivery devices and primary packaging. With ISO 13485 certification, FDA-cleared products, and state-of-the-art manufacturing facilities, it serves as a critical industrialization partner for leading pharmaceutical and medical device companies, enabling reliable and scalable delivery of injectable treatments.
Technology Platform
Proprietary SafeR® platform for passive safety syringe systems, and a comprehensive CDMO technology stack for injectable drug delivery device development and manufacturing, including advanced polymer processing, material science, and automated assembly.
Opportunities
Risk Factors
Competitive Landscape
Roncadelle competes in the fragmented but competitive medical device CDMO and safety syringe markets. Key competitors include large, established players like West Pharmaceutical Services, Gerresheimer, and Schott, as well as numerous specialized contract manufacturers. Differentiation is achieved through integrated 'concept-to-scale' services, proprietary SafeR® technology, and deep expertise in polymer processing and industrialization for injectables.